AstriVax, a Belgian biotech company founded in 2022, has appointed Dr. Mathieu Peeters as Chief Development Officer and Barbara Freitag as Chief Financial Officer to enhance its leadership team as it transitions to clinical development stages.

Serum Institute of India, the world's largest vaccine maker, believes its malaria vaccine has the potential to significantly reduce fatalities from the disease, particularly among young children in Africa. The vaccine, developed in partnership with researchers at the University of Oxford, has gained a World Health Organization recommendation for use in Africa for children under five years old. Serum Institute plans to produce 100 million doses of the vaccine annually, with 20 million already in stock, and expects to start distribution next year. The cost of the vaccine will be less than $4 per shot, cheaper than what is currently available.

BiondVax Pharmaceuticals Ltd. announced that its CEO Amir Reichman will present at the BIO-Europe Spring event in Basel, Switzerland, from March 20-22, 2023. The event will feature over 2,800 executives from biotech and pharma industries. BiondVax will discuss its innovative inhaled COVID-19 treatment and its pipeline of nanosized antibodies for autoimmune diseases.

The global Flu Vaccines Market is currently valued at approximately US$ 5.06 billion in 2022 and is projected to reach US$ 10.19 billion by 2033, growing at a CAGR of 6.70%. This growth is driven by increased flu prevalence, rising demand for vaccines, especially in developing countries, and government initiatives promoting vaccination. The market is also influenced by advancements in vaccine technology and the impact of the COVID-19 pandemic.

The H5N1 avian influenza has affected 76 countries, leading to 140 million poultry deaths worldwide. Industry experts in the US are considering vaccinating commercial poultry against the flu, despite potential trade bans and consumer concerns. The discussion is urgent due to the virus's impact on wild birds and its adaptation to mammals.